The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global home infusion therapy market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.
Home infusion therapy is a medical procedure used for the (IV) or subcutaneous administration of drugs or biologics to a patient at home. It involves the infusion of medications, such as antivirals or immune globin, through various equipment, including pumps, catheters and vials. The therapy is effective in chemotherapy and hydration, enteral, inotropic, anti-infective, nutritional and pain management therapies for the treatment of diabetes and various gastrointestinal and oncological disorders. It facilitates self-administration of drugs in medical conditions where oral medications are not effective.
The increasing prevalence of chronic medical ailments, such as cancer, osteoarthritis and diabetes, and the shifting preference for at-home treatments among the masses, is one of the key factors driving the growth of the market. The rising incidence of hospital-acquired infections (HAIs) due to exposure to contaminated equipment, bed linens and air droplets across facilities is also providing a thrust to the market growth. Moreover, as the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for home infusion therapies to minimize the risks of contracting the infection and ensuring optimal treatment. Additionally, the development of cost-effective and user-friendly home infusion kits is acting as another growth-inducing factor. These novel variants are lightweight, portable and easy to use for the patients and caregivers and are also equipped with advanced drip systems for precise and real-time monitoring of IV treatments. Other factors, including the rising geriatric population, which is more susceptible to medical ailments, along with significant improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global home infusion therapy market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product and application.
Breakup by Product:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Eli Lilly and Company, Fresenius SE & Co. KGaA, ICU Medical Inc., JMS Co. Ltd., Nipro Corporation, Option Care Health Inc. (Walgreen Co.), Smiths Group plc and Terumo Corporation.
|Base Year of the Analysis||2020|
|Segment Coverage||Product, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Eli Lilly and Company, Fresenius SE & Co. KGaA, ICU Medical Inc., JMS Co. Ltd., Nipro Corporation, Option Care Health Inc. (Walgreen Co.), Smiths Group plc and Terumo Corporation.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at